Skip to content

FDA.reportPublic FDA data

NDC RxNorm DailyMed Applications GUDID GMDN PMA PMN MAUDE Recalls

Search FDA.report

Home
Applications
216504

Application 216504

Type: ANDA
Sponsor: AUROBINDO PHARMA

Related Records#

Company: AUROBINDO PHARMA

Application Products#

Product, Drug, Ingredient table
Product	Drug	Ingredient	Form	Strength	Reference drug	Reference standard
001	NAPROXEN	NAPROXEN	SUSPENSION;ORAL	25MG/ML	No	No

FDA.report indexes public FDA datasets and legacy FDA.report records. Source data can change; verify critical regulatory decisions with the official FDA source.

Sitemap Robots Ads.txt